Inhibiting KAT2B could promote proliferation together with metastasis of cervical cancer cell line C33A, while KAT2B overexpression was capable of inhibiting proliferation as well as metastasis of cervical cancer cell line CaSki. Here, KAT2B is linked to cervical cancer.